Abstract Details
|
Sarada Sakamuri, MD, FAAN
PRESENTER |
Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with AANEM. Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with ISNMI Neuromuscular Ultrasound Workshop. Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with Wake Forest University. Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with Wake Forest University. |
| Carly Siskind, MS | Ms. Siskind has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Thomas L. Winder, PhD, FACMG (Invitae Corp.) | Dr. Winder has nothing to disclose. |
| Hannes Vogel, MD (Stanford Univ Med Cen/ Dept of Pathology) | Dr. Vogel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lipton Law . Dr. Vogel has received publishing royalties from a publication relating to health care. |
| John W. Day, MD, PhD (Stanford University School of Medicine) | Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PepGen. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epirium Bio. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Astellas Pharma. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. The institution of Dr. Day has received research support from AMO Pharma. The institution of Dr. Day has received research support from AnnJi. Dr. Day has received research support from CureSMA. The institution of Dr. Day has received research support from Muscular Dystrophy Association. The institution of Dr. Day has received research support from Ionis Pharmaceuticals. The institution of Dr. Day has received research support from NMD Pharma. The institution of Dr. Day has received research support from SMA Foundation. Dr. Day has received intellectual property interests from a discovery or technology relating to health care. |